Published in Infect Immun on February 01, 1982
Berberine improves glucose metabolism through induction of glycolysis. Am J Physiol Endocrinol Metab (2007) 2.09
Berberine promotes recovery of colitis and inhibits inflammatory responses in colonic macrophages and epithelial cells in DSS-treated mice. Am J Physiol Gastrointest Liver Physiol (2011) 1.12
Biological screening of natural products and drug innovation in China. Philos Trans R Soc Lond B Biol Sci (2007) 1.04
Agents that act luminally to treat diarrhoea and constipation. Nat Rev Gastroenterol Hepatol (2012) 0.99
Modulating gut microbiota as an anti-diabetic mechanism of berberine. Med Sci Monit (2011) 0.95
Small molecule adenosine 5'-monophosphate activated protein kinase (AMPK) modulators and human diseases. J Med Chem (2014) 0.84
Berberine inhibition of electrogenic ion transport in rat colon. Br J Pharmacol (1995) 0.83
Berberine sulfate blocks adherence of Streptococcus pyogenes to epithelial cells, fibronectin, and hexadecane. Antimicrob Agents Chemother (1988) 0.81
Weak C-H···X (X = O, N) hydrogen bonds in the crystal structure of dihydroberberine. Acta Crystallogr C Struct Chem (2014) 0.81
Berberine blocks the relapse of Clostridium difficile infection in C57BL/6 mice after standard vancomycin treatment. Antimicrob Agents Chemother (2015) 0.80
Clinical trial of berberine in acute watery diarrhoea. Br Med J (Clin Res Ed) (1985) 0.80
Reversal of the biological activity of Escherichia coli heat-stable enterotoxin by disulfide-reducing agents. Infect Immun (1986) 0.79
Berberine protects against light-induced photoreceptor degeneration in the mouse retina. Exp Eye Res (2015) 0.78
A review on biological and chemical diversity in Berberis (Berberidaceae). EXCLI J (2015) 0.77
Antibacterial and antidiarrheal activities of plant products against enterotoxinogenic Escherichia coli. Toxins (Basel) (2013) 0.76
Development of ITS sequence-based markers to distinguish Berberis aristata DC. from B. lycium Royle and B. asiatica Roxb. 3 Biotech (2011) 0.76
Modulation of murine Peyer's patch immunoglobulin A response by enterotoxigenic Escherichia coli. Infect Immun (1987) 0.75
Inhibiting Microbial Toxins Using Plant-Derived Compounds and Plant Extracts. Medicines (Basel) (2015) 0.75
Berberis vulgaris and its constituent berberine as antidotes and protective agents against natural or chemical toxicities. Iran J Basic Med Sci (2017) 0.75
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
Test for Escherichia coli enterotoxin using infant mice: application in a study of diarrhea in children in Honolulu. J Infect Dis (1972) 24.30
An experimental study of the mechanism of action of Vibriod cholerae on the intestinal mucous membrane. J Pathol Bacteriol (1953) 11.72
Differences in the response of rabbit small intestine to heat-labile and heat-stable enterotoxins of Escherichia coli. Infect Immun (1973) 8.47
Radioimmunoassay for cyclic nucleotides. I. Preparation of antibodies and iodinated cyclic nucleotides. J Biol Chem (1972) 8.24
Stimulation of adenyl cyclase by Escherichia coli enterotoxin. Nat New Biol (1972) 6.65
Heat-stable enterotoxin of Escherichia coli: in vitro effects on guanylate cyclase activity, cyclic GMP concentration, and ion transport in small intestine. Proc Natl Acad Sci U S A (1978) 6.01
Elevated concentration of adenosine 3':5'-cyclic monophosphate in intestinal mucosa after treatment with cholera toxin. Proc Natl Acad Sci U S A (1970) 3.41
Laboratory investigation of diarrhea in travelers to Mexico: evaluation of methods for detecting enterotoxigenic Echerichia coli. J Clin Microbiol (1976) 3.34
Berberine sulfate: antimicrobial activity, bioassay, and mode of action. Can J Microbiol (1969) 1.89
Reversal of cyclic AMP-mediated intestinal secretion in mice by chlorpromazine. Gastroenterology (1978) 1.32
Challenge of dogs with live enterotoxigenic Escherichia coli and effects of repeated challenges on fluid secretion in jejunal Thiry-Vella loops. J Infect Dis (1976) 1.30
Berberine and chloramphenicol in the treatment of cholera and severe diarrhoea. J Indian Med Assoc (1967) 1.23
Chlorpromazine reduces fluid-loss in cholera. Lancet (1979) 1.12
Effect of berberine sulphate on Entamoeba histolytica. Nature (1967) 1.12
Effect of chlorpromazine on the secretory activity of Escherichia coli heat-stable enterotoxin. Infect Immun (1979) 0.98
Anti-inflammatory effect of berberine in rats injected locally with cholera toxin. Indian J Med Res (1977) 0.96
Possible mechanism of antidiarrhoeal effect of berberine. Indian J Med Res (1979) 0.92
Antagonism of cholera toxin by berberine in the gastrointestinal tract of adult rats. Indian J Med Res (1977) 0.87
Use of berberine in treatment of giardiasis. Am J Dis Child (1975) 0.84
Prevention and reversal of cholera enterotoxin effects in rabbit jejunum by nicotinic acid. J Clin Invest (1978) 0.83
Kala-azar in Gujarat. J Indian Med Assoc (1972) 0.82
Intestinal secretion. Int Rev Physiol (1977) 0.80
Test for enterotoxigenic Escherichia coli using Y-1 adrenal cells in miniculture. Infect Immun (1975) 13.58
Human diarrheal disease caused by enterotoxigenic Escherichia coli. Annu Rev Microbiol (1975) 9.01
Enterotoxigenic Escherichia coli isolated from patients with severe cholera-like disease. J Infect Dis (1971) 7.10
Travelers' diarrhea in Mexico. A prospective study of physicians and family members attending a congress. N Engl J Med (1976) 6.52
Acute undifferentiated human diarrhea in the tropics. I. Alterations in intestinal micrflora. J Clin Invest (1971) 6.23
Large outbreak of clinical cholera due to Vibrio cholerae non-O1 in Bangladesh. Lancet (1993) 5.48
Immunologic cross-reactions of enterotoxins from Escherichia coli and Vibrio cholerae. J Infect Dis (1973) 5.46
Enzyme-linked immunosorbent assay for detection of Escherichia coli heat-labile enterotoxin. J Clin Microbiol (1977) 5.17
Special Escherichia coli serotypes among enterotoxigenic strains from diarrhoea in adults and children. Med Microbiol Immunol (1976) 4.95
Practice guidelines for the management of infectious diarrhea. Clin Infect Dis (2001) 4.49
Experimental canine cholera. I. Development of the model. J Infect Dis (1969) 4.02
Site and characteristics of electrolyte loss and effect of intraluminal glucose in experimental canine cholera. J Clin Invest (1968) 3.72
Simple adult rabbit model for Vibrio cholerae and enterotoxigenic Escherichia coli diarrhea. Infect Immun (1981) 3.69
Cytotoxic enterotoxin produced by Aeromonas hydrophila: relationship of toxigenic isolates to diarrheal disease. Infect Immun (1979) 3.65
Enterotoxigenic Escherichia coli isolated from food. J Infect Dis (1977) 3.52
Laboratory investigation of diarrhea in travelers to Mexico: evaluation of methods for detecting enterotoxigenic Echerichia coli. J Clin Microbiol (1976) 3.34
Diarrhoea associated with heat-stable enterotoxin-producing strains of Escherichia coli. Lancet (1975) 3.27
Oral rehydration therapy of infantile diarrhea: a controlled study of well-nourished children hospitalized in the United States and Panama. N Engl J Med (1982) 3.24
Case-control study of enteropathogens associated with childhood diarrhea in Dhaka, Bangladesh. J Clin Microbiol (1999) 3.11
Intestinal fluid and electrolyte transport in human cholera. J Clin Invest (1970) 3.09
A controlled trial of bismuth subsalicylate in infants with acute watery diarrheal disease. N Engl J Med (1993) 3.07
Progressive changes of Vibrio serotypes in germ-free mice infected with Vibrio cholerae. J Bacteriol (1969) 3.01
Antitoxin responses to infections with enterotoxigenic Escherichia coli. J Infect Dis (1974) 2.88
Prophylactic doxycycline for travelers' diarrhea. Results of a prospective double-blind study of Peace Corps volunteers in Kenya. N Engl J Med (1978) 2.86
Enterotoxigenic Escherichia-coli-associated diarrheal disease in Apache children. N Engl J Med (1975) 2.74
Microtiter solid-phase radioimmunoassay for detection of Escherichia coli heat-labile enterotoxin. Infect Immun (1977) 2.72
Prevalence of toxin types and colonization factors in enterotoxigenic Escherichia coli isolated during a 2-year period from diarrheal patients in Bangladesh. J Clin Microbiol (2000) 2.69
Vibriocidal and agglutinating antibody patterns in cholera patients. J Infect Dis (1966) 2.67
El Tor cholera with severe disease: a new threat to Asia and beyond. Epidemiol Infect (2009) 2.60
Isolation of enterotoxigenic Bacteroides fragilis from humans with diarrhea. J Clin Microbiol (1987) 2.58
Methodological issues in diarrhoeal diseases epidemiology: definition of diarrhoeal episodes. Int J Epidemiol (1991) 2.56
Human colonic epithelial cells, HT29/C1, treated with crude Bacteroides fragilis enterotoxin dramatically alter their morphology. Infect Immun (1992) 2.41
Genotypes associated with virulence in environmental isolates of Vibrio cholerae. Appl Environ Microbiol (2001) 2.41
Replacement of water and electrolyte losses in cholera by an oral glucose-electrolyte solution. Ann Intern Med (1969) 2.28
Tissue-culture assay of antibodies to heat-liable Escherichia coli enterotoxins. N Engl J Med (1974) 2.20
Amebiasis and mucosal IgA antibody against the Entamoeba histolytica adherence lectin in Bangladeshi children. J Infect Dis (2001) 2.20
Enterotoxigenic Escherichia coli: identification and characterization. J Infect Dis (1980) 2.16
Immunity to experimental cholera. III. Enhanced duration of protection after sequential parenteral-oral administration of toxoid to dogs. J Infect Dis (1977) 2.13
Small bowel morphology in experimental canine cholera. A light and electron microscopic study. Lab Invest (1970) 2.12
Production, characterization, and application of monoclonal antibodies to Vibrio cholerae O139 synonym Bengal. Clin Diagn Lab Immunol (1994) 2.07
The aquatic flora and fauna as reservoirs of Vibrio cholerae: a review. J Diarrhoeal Dis Res (1994) 2.04
Enterotoxigenic Escherichia coli isolated from patients at a hospital in Dacca. J Infect Dis (1977) 2.03
Comparison of immune responses in patients infected with Vibrio cholerae O139 and O1. Infect Immun (1997) 2.01
Relationship between enterotoxin production and serotype in enterotoxigenic Escherichia coli. Infect Immun (1979) 2.01
Cholera epidemics in Bangladesh: 1985-1991. J Diarrhoeal Dis Res (1992) 1.92
Enteropathogens associated with acute and persistent diarrhea in Bangladeshi children less than 5 years of age. J Infect Dis (1992) 1.91
Comparison of the vibriocidal antibody response in cholera due to Vibrio cholerae O139 Bengal with the response in cholera due to Vibrio cholerae O1. Clin Diagn Lab Immunol (1995) 1.89
Use of colony pools for diagnosis of enterotoxigenic Escherichia coli diarrhea. J Clin Microbiol (1979) 1.88
Enterotoxigenic Escherichia coli diarrhea of travelers: a prospective study of American Peace Corps volunteers. Johns Hopkins Med J (1977) 1.88
Experimental cholera. A canine model. Lancet (1966) 1.88
Acute toxicity of vitamin A given with vaccines in infancy. Lancet (1993) 1.87
Immunization with Escherichia coli enterotoxin protects against homologous enterotoxin challenge. Infect Immun (1973) 1.86
Prevalence of enterotoxin genes in Aeromonas spp. isolated from children with diarrhea, healthy controls, and the environment. J Clin Microbiol (2000) 1.85
Prophylactic doxycycline for travelers' diarrhea: results of a prospective double-blind study of Peace Corps volunteers in Morocco. Gastroenterology (1979) 1.84
Molecular analysis of rRNA and cholera toxin genes carried by the new epidemic strain of toxigenic Vibrio cholerae O139 synonym Bengal. J Clin Microbiol (1994) 1.79
The O139 serogroup of Vibrio cholerae comprises diverse clones of epidemic and nonepidemic strains derived from multiple V. cholerae O1 or non-O1 progenitors. J Infect Dis (2000) 1.76
Antibodies to heat-labile Escherichia coli enterotoxin in Apaches in Whiteriver, Arizona. Infect Immun (1975) 1.75
Experimental canine cholera. II. Production by cell-free culture filtrates of Vibrio cholerae. J Infect Dis (1969) 1.69
New insights on the emergence of cholera in Latin America during 1991: the Peruvian experience. Am J Trop Med Hyg (2000) 1.66
The spatial epidemiology of cholera in an endemic area of Bangladesh. Soc Sci Med (2002) 1.65
Acute respiratory infections in children: a community-based longitudinal study in rural Bangladesh. J Trop Pediatr (1997) 1.64
Antigenic similarity of heat-labile enterotoxins from diverse strains of Escherichia coli. J Clin Microbiol (1977) 1.55
Identifying environmental risk factors for endemic cholera: a raster GIS approach. Health Place (2002) 1.49
Development and evaluation of rapid monoclonal antibody-based coagglutination test for direct detection of Vibrio cholerae O139 synonym Bengal in stool samples. J Clin Microbiol (1994) 1.47
The efficacy of bismuth subsalicylate in the treatment of acute diarrhoea and the prevention of persistent diarrhoea. Acta Paediatr (2001) 1.47
Rotavirus diarrhea in Bangladeshi children: correlation of disease severity with serotypes. J Clin Microbiol (1992) 1.44
The current status of oral therapy in the treatment of acute diarrheal illness. Am J Clin Nutr (1978) 1.43
Molecular epidemiology of a parainfluenza type 3 virus outbreak on a pediatric ward. J Infect Dis (1993) 1.43
Diagnostic limitations to accurate diagnosis of cholera. J Clin Microbiol (2010) 1.43
Comparison of three methods to obtain upper small bowel contents for culture. Am J Gastroenterol (1993) 1.41
Colonization factor antigens I and II and type 1 somatic pili in enterotoxigenic Escherichia coli: relation to enterotoxin type. Infect Immun (1983) 1.41
Molecular subtyping of toxigenic Vibrio cholerae O139 causing epidemic cholera in India and Bangladesh, 1992-1993. J Infect Dis (1995) 1.37
Clonal relationships among classical Vibrio cholerae O1 strains isolated between 1961 and 1992 in Bangladesh. J Clin Microbiol (1993) 1.36
Early treatment with erythromycin of Campylobacter jejuni-associated dysentery in children. J Pediatr (1986) 1.36
Differentiation of Shigella flexneri strains by rRNA gene restriction patterns. J Clin Microbiol (1992) 1.35
Comparison of sucrose and glucose in the oral electrolyte therapy of cholera and other severe diarrheas. N Engl J Med (1977) 1.35
Lack of cross-protection against diarrhea due to Vibrio cholerae O139 (Bengal strain) after oral immunization of rabbits with V. cholerae O1 vaccine strain CVD103-HgR. J Infect Dis (1994) 1.35
Role of soy-based, lactose-free formula during treatment of acute diarrhea. Pediatrics (1985) 1.34
Molecular characterization of a new ribotype of Vibrio cholerae O139 Bengal associated with an outbreak of cholera in Bangladesh. J Clin Microbiol (1999) 1.30
Challenge of dogs with live enterotoxigenic Escherichia coli and effects of repeated challenges on fluid secretion in jejunal Thiry-Vella loops. J Infect Dis (1976) 1.30
Evaluation of the monoclonal antibody-based kit Bengal SMART for rapid detection of Vibrio cholerae O139 synonym Bengal in stool samples. J Clin Microbiol (1995) 1.29
Detection of Escherichia coli enterotoxins in stools. Infect Immun (1980) 1.28
The aquatic environment as a reservoir of Vibrio cholerae: a review. J Diarrhoeal Dis Res (1993) 1.28
The relationship of superior mesenteric artery blood flow to gut electrolyte loss in experimental cholera. J Infect Dis (1969) 1.27
Disease due to enterotoxigenic Escherichia coli in Bangladeshi adults: clinical aspects and a controlled trial of tetracycline. J Infect Dis (1980) 1.27
Epidemiological and clinical characteristics of acute and persistent diarrhoea in rural Bangladeshi children. Acta Paediatr Suppl (1992) 1.26
Genomic diversity among Vibrio cholerae O139 strains isolated in Bangladesh and India between 1992 and 1998. FEMS Microbiol Lett (2000) 1.26
The use of oral replacement solutions in the treatment of choleraand other severe diarrhoeal disorders. Bull World Health Organ (1970) 1.25
Antimicrobial resistance and serotype distribution of Streptococcus pneumoniae strains causing childhood infections in Bangladesh, 1993 to 1997. J Clin Microbiol (1999) 1.25
Rapid detection of parainfluenza virus type 3 RNA in respiratory specimens: use of reverse transcription-PCR-enzyme immunoassay. J Clin Microbiol (1994) 1.25
Gastric acidity in cholera and noncholera diarrhoea. Bull World Health Organ (1972) 1.23
Validation of a volunteer model of cholera with frozen bacteria as the challenge. Infect Immun (1998) 1.23
Increasing frequency of mecillinam-resistant shigella isolates in urban Dhaka and rural Matlab, Bangladesh: a 6 year observation. J Antimicrob Chemother (1998) 1.22
Sustainability of a water, sanitation and hygiene education project in rural Bangladesh: a 5-year follow-up. Bull World Health Organ (1996) 1.22
Etiologic agents in acute vs persistent diarrhea in children under three years of age in peri-urban Lima, Perú. Acta Paediatr Suppl (1992) 1.22
Probable role of blue-green algae in maintaining endemicity and seasonality of cholera in Bangladesh: a hypothesis. J Diarrhoeal Dis Res (1994) 1.20